Significant:
Stevens-Johnson syndrome, toxic epidermal necrolysis (TEN)/Lyell’s syndrome, hypersensitivity, renal and gallbladder precipitation, pancreatitis secondary to biliary obstruction, renal lithiasis, superinfection.
Blood and lymphatic system disorders:
Eosinophilia, leucopenia, thrombocytopenia.
Gastrointestinal disorders:
Diarrhoea, oral candidiasis.
General disorders and administration site conditions:
Diaphoresis. Injury, poisoning and procedural complications: Pain, induration and tenderness at injection site (IM).
Investigations:
Increased hepatic enzymes, BUN and serum creatinine; sonographic abnormalities in the gallbladder.
Nervous system disorders:
Headache, dizziness.
Reproductive system and breast disorders:
Candidal vaginitis.
Skin and subcutaneous tissue disorders:
Rash.
Vascular disorders:
Flushing.
Potentially Fatal:
Severe haemolytic anaemia, Clostridium difficile associated diarrhoea (CDAD).